Manika V Kaushal, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: 058415 · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kaushal’s office at (408) 997-9155 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A97286 · Current
Licensed to practise in California · since 2006 · expires 2028-05-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$44,124
Medicare paid this office $44,124 for 185 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 146 | $28,923 | $109 |
| Short return visit (20+ min) | 43 | $4,041 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $3,215 | $153 |
| Long return visit (40+ min) | 18 | $2,737 | $144 |
| New patient visit (45+ min) | 13 | $1,508 | $116 |
See all 7 services
| Return visit (30+ min) | 146 | $28,923 | $109 |
| Short return visit (20+ min) | 43 | $4,041 | $79 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $3,215 | $153 |
| Long return visit (40+ min) | 18 | $2,737 | $144 |
| New patient visit (45+ min) | 13 | $1,508 | $116 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $662 | $41 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 31 | $478 | $14 |
Who their Medicare patients are
185 Original Medicare patients in 2024. Average age 75 · Women 70% · Also on Medicaid 17% · Health risk score 1.17. Above the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 30% · Coronary heart disease 25% · Chronic kidney disease 19% · Atrial fibrillation 19% · Cancer 18% · Depression 16% · Heart failure 15% · COPD 12% · Dementia 8% · Stroke 8%.
The office billed $169,894, Medicare allowed $61,796 and paid $44,124; for 452 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 185 | 452 | 75 | 1.17 | $169,894 | $44,124 |
| 2023 | 200 | 406 | 74 | 1.09 | $134,449 | $36,974 |
| 2022 | 164 | 282 | 75 | 1.00 | $100,190 | $26,381 |
| 2021 | 132 | 261 | 74 | 1.11 | $95,574 | $26,697 |
| 2020 | 96 | 180 | 75 | 0.93 | $49,680 | $11,682 |
| 2019 | 152 | 397 | 75 | 0.86 | $116,847 | $25,942 |
| 2018 | 142 | 318 | 74 | 0.86 | $90,435 | $22,203 |
| 2017 | 81 | 175 | 75 | 0.88 | $42,767 | $9,631 |
| 2016 | 142 | 304 | 75 | 0.91 | $80,309 | $20,628 |
| 2015 | 84 | 164 | 74 | 1.00 | $39,492 | $10,568 |
| 2014 | 132 | 311 | 74 | 1.00 | $63,813 | $19,158 |
| 2013 | 96 | 227 | 75 | 0.96 | $33,235 | $14,909 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 109 | $16,930 | $101 |
| Short return visit (20+ min) | 59 | $5,166 | $73 |
| Influenza vaccine split virus, preservative free | 40 | $2,877 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,806 | $156 |
| New patient visit (45+ min) | 15 | $2,176 | $145 |
| Administration of influenza virus vaccine | 40 | $1,478 | $37 |
2022: 4 services
| Return visit (30+ min) | 88 | $14,119 | $111 |
| Short return visit (20+ min) | 54 | $5,500 | $82 |
| Telephone medical discussion with physician, 11-20 minutes | 31 | $2,780 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,893 | $111 |
2021: 5 services
| Return visit (30+ min) | 54 | $9,653 | $122 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $6,336 | $87 |
| Short return visit (20+ min) | 41 | $5,232 | $92 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $2,400 | $109 |
| New patient visit (45+ min) | 15 | $2,045 | $136 |
2020: 4 services
| Return visit (30+ min) | 30 | $2,789 | $80 |
| Short return visit (20+ min) | 46 | $2,729 | $45 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,481 | $103 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $1,249 | $78 |
2019: 8 services
| Short return visit (20+ min) | 104 | $10,148 | $64 |
| Return visit (30+ min) | 57 | $7,127 | $85 |
| Pneumococcal vaccine, 23-valent | 13 | $1,455 | $112 |
| Influenza vaccine split virus, preservative free | 13 | $711 | $55 |
| Administration of pneumococcal vaccine | 21 | $431 | $21 |
| Administration of influenza virus vaccine | 15 | $308 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 12 | $181 | $14 |
| Automated urinalysis test | 16 | $46 | $2 |
2018: 4 services
| Short return visit (20+ min) | 101 | $8,745 | $59 |
| Return visit (30+ min) | 55 | $6,200 | $90 |
| Pneumococcal vaccine, 13-valent | 11 | $2,199 | $200 |
| Administration of pneumococcal vaccine | 18 | $463 | $26 |
2017: 2 services
| Short return visit (20+ min) | 62 | $4,754 | $55 |
| Return visit (30+ min) | 29 | $2,663 | $74 |
2016: 3 services
| Return visit (30+ min) | 65 | $9,209 | $88 |
| Short return visit (20+ min) | 104 | $7,562 | $58 |
| Urinalysis, manual test | 12 | $48 | $3 |
2015: 2 services
| Short return visit (20+ min) | 59 | $4,685 | $58 |
| Return visit (30+ min) | 30 | $3,535 | $91 |
2014: 3 services
| Short return visit (20+ min) | 88 | $7,455 | $53 |
| Return visit (30+ min) | 52 | $6,864 | $86 |
| Urinalysis, manual test | 20 | $75 | $3 |
2013: 3 services
| Short return visit (20+ min) | 68 | $6,459 | $60 |
| Return visit (30+ min) | 43 | $5,754 | $87 |
| Urinalysis, manual test | 13 | $45 | $3 |
Drugs they prescribed that Part D paid
$98,188
Pharmacies billed $98,188 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,291 generic and fewer than 11 brand-name prescriptions · $98,188 in drug cost · 42 antibiotic prescriptions to 35 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 13 | $19,390 | $1,492 |
| Anoro Ellipta | 11 | $4,437 | $403 |
| Levothyroxine | 106 | $778 | $7 |
| Atorvastatin | 97 | $702 | $7 |
| Omeprazole | 53 | $660 | $12 |
See all 32 drugs
| Eliquis | 13 | $19,390 | $1,492 |
| Anoro Ellipta | 11 | $4,437 | $403 |
| Levothyroxine | 106 | $778 | $7 |
| Atorvastatin | 97 | $702 | $7 |
| Omeprazole | 53 | $660 | $12 |
| Amlodipine Besylate | 91 | $641 | $7 |
| Ezetimibe | 18 | $609 | $34 |
| Lisinopril | 64 | $550 | $9 |
| Rosuvastatin | 29 | $536 | $18 |
| Gabapentin | 40 | $519 | $13 |
| Losartan | 56 | $440 | $8 |
| Metoprolol | 32 | $438 | $14 |
| Metformin | 42 | $412 | $10 |
| Simvastatin | 35 | $404 | $12 |
| Metformin Hcl Er | 23 | $286 | $12 |
| Pantoprazole | 22 | $267 | $12 |
| Albuterol Sulfate Hfa | 19 | $262 | $14 |
| Citalopram Hbr | 18 | $246 | $14 |
| Montelukast | 18 | $224 | $12 |
| Fluticasone Propionate | 19 | $162 | $9 |
| Hydrochlorothiazide | 47 | $158 | $3 |
| Pravastatin | 12 | $156 | $13 |
| Losartan-Hydrochlorothiazide | 14 | $149 | $11 |
| Escitalopram | 19 | $135 | $7 |
| Zolpidem | 18 | $117 | $6 |
| Atenolol | 13 | $111 | $9 |
| Metoprolol | 15 | $72 | $5 |
| Furosemide | 12 | $66 | $5 |
| Sertraline | 12 | $63 | $5 |
| Fluoxetine | 17 | $43 | $3 |
| Glipizide | 11 | $37 | $3 |
| Alendronate | 12 | $31 | $3 |
Year by year
| 2024 | 1,397 | 225 | None | None | $98,188 |
| 2023 | 1,196 | 203 | None | None | $51,270 |
| 2022 | 994 | 173 | None | 9% | $50,599 |
| 2021 | 869 | 153 | None | 14% | $60,145 |
| 2020 | 714 | 119 | 0% (0) | 15% | $34,733 |
| 2019 | 1,119 | 188 | None | None | $54,589 |
| 2018 | 1,112 | 169 | None | 10% | $55,738 |
| 2017 | 755 | 113 | None | 10% | $34,063 |
| 2016 | 1,044 | 146 | None | None | $42,343 |
| 2015 | 863 | 102 | None | 19% | $36,859 |
| 2014 | 1,124 | 129 | None | 16% | $40,158 |
| 2013 | 873 | 99 | None | None | $30,076 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Levothyroxine | 97 | $1,306 | $13 |
| Atorvastatin | 74 | $933 | $13 |
| Gabapentin | 37 | $823 | $22 |
| Metformin | 45 | $821 | $18 |
| Albuterol Sulfate Hfa | 25 | $777 | $31 |
| Lisinopril | 70 | $751 | $11 |
| Amlodipine Besylate | 67 | $675 | $10 |
| Losartan | 65 | $661 | $10 |
| Metoprolol | 34 | $487 | $14 |
| Metformin Hcl Er | 17 | $470 | $28 |
| Simvastatin | 43 | $431 | $10 |
| Rosuvastatin | 17 | $388 | $23 |
| Omeprazole | 19 | $312 | $16 |
| Fenofibrate | 11 | $243 | $22 |
| Montelukast | 15 | $225 | $15 |
| Alendronate | 29 | $222 | $8 |
| Escitalopram | 16 | $200 | $12 |
| Metoprolol | 17 | $163 | $10 |
| Citalopram Hbr | 18 | $159 | $9 |
| Zolpidem | 18 | $142 | $8 |
| Furosemide | 19 | $135 | $7 |
| Glipizide | 16 | $133 | $8 |
| Hydrochlorothiazide | 40 | $133 | $3 |
| Amoxicillin-Clavulanate Potass | 14 | $121 | $9 |
| Cyclobenzaprine | 12 | $85 | $7 |
| Sertraline | 11 | $82 | $7 |
| Azithromycin | 17 | $77 | $5 |
| Fluoxetine | 19 | $47 | $2 |
2022: 24 drugs
| Advair Diskus | 13 | $9,269 | $713 |
| Humulin N Kwikpen | 13 | $7,181 | $552 |
| Levothyroxine | 99 | $1,490 | $15 |
| Albuterol Sulfate Hfa | 22 | $736 | $33 |
| Atorvastatin | 75 | $718 | $10 |
| Losartan | 47 | $513 | $11 |
| Sertraline | 21 | $499 | $24 |
| Metformin Hcl Er | 20 | $497 | $25 |
| Rosuvastatin | 12 | $424 | $35 |
| Metoprolol | 25 | $406 | $16 |
| Lisinopril | 58 | $370 | $6 |
| Pravastatin | 12 | $334 | $28 |
| Amoxicillin-Clavulanate Potass | 29 | $322 | $11 |
| Glipizide | 14 | $319 | $23 |
| Metformin | 39 | $306 | $8 |
| Amlodipine Besylate | 51 | $280 | $5 |
| Montelukast | 15 | $275 | $18 |
| Simvastatin | 43 | $245 | $6 |
| Venlafaxine Hcl Er | 12 | $242 | $20 |
| Metoprolol | 18 | $189 | $10 |
| Gabapentin | 18 | $184 | $10 |
| Hydrochlorothiazide | 41 | $142 | $3 |
| Alendronate | 16 | $82 | $5 |
| Azithromycin | 18 | $81 | $5 |
2021: 21 drugs
| Advair Diskus | 14 | $9,220 | $659 |
| Levothyroxine | 70 | $1,358 | $19 |
| Atorvastatin | 61 | $736 | $12 |
| Losartan | 34 | $551 | $16 |
| Lisinopril | 46 | $335 | $7 |
| Metoprolol | 19 | $320 | $17 |
| Pravastatin | 16 | $304 | $19 |
| Citalopram Hbr | 11 | $290 | $26 |
| Nitrofurantoin Mono-Macro | 14 | $282 | $20 |
| Metoprolol | 21 | $237 | $11 |
| Sertraline | 17 | $232 | $14 |
| Gabapentin | 12 | $227 | $19 |
| Amlodipine Besylate | 46 | $203 | $4 |
| Simvastatin | 39 | $196 | $5 |
| Metformin | 29 | $186 | $6 |
| Montelukast | 13 | $179 | $14 |
| Glipizide | 15 | $160 | $11 |
| Hydrochlorothiazide | 32 | $130 | $4 |
| Propranolol | 12 | $91 | $8 |
| Metformin Hcl Er | 11 | $90 | $8 |
| Hydralazine | 16 | $68 | $4 |
2020: 18 drugs
| Advair Diskus | 12 | $8,882 | $740 |
| Levothyroxine | 72 | $1,345 | $19 |
| Losartan | 41 | $532 | $13 |
| Rosuvastatin | 11 | $413 | $38 |
| Atorvastatin | 31 | $400 | $13 |
| Lisinopril | 37 | $240 | $6 |
| Metoprolol | 16 | $223 | $14 |
| Hydrochlorothiazide | 38 | $210 | $6 |
| Nitrofurantoin Mono-Macro | 13 | $202 | $16 |
| Amlodipine Besylate | 43 | $198 | $5 |
| Metoprolol | 12 | $185 | $15 |
| Lisinopril-Hydrochlorothiazide | 22 | $175 | $8 |
| Simvastatin | 38 | $168 | $4 |
| Montelukast | 14 | $147 | $10 |
| Metformin | 23 | $125 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $118 | $10 |
| Metformin Hcl Er | 11 | $96 | $9 |
| Hydralazine | 11 | $69 | $6 |
2019: 24 drugs
| Eliquis | 13 | $6,168 | $474 |
| Levothyroxine | 89 | $2,017 | $23 |
| Atorvastatin | 54 | $757 | $14 |
| Losartan | 47 | $561 | $12 |
| Metoprolol | 26 | $556 | $21 |
| Amlodipine Besylate | 68 | $541 | $8 |
| Allopurinol | 19 | $474 | $25 |
| Amoxicillin-Clavulanate Potass | 39 | $470 | $12 |
| Escitalopram | 28 | $465 | $17 |
| Simvastatin | 61 | $390 | $6 |
| Hydrochlorothiazide | 51 | $387 | $8 |
| Lisinopril | 46 | $359 | $8 |
| Metformin | 47 | $347 | $7 |
| Alendronate | 18 | $323 | $18 |
| Omeprazole | 24 | $312 | $13 |
| Montelukast | 26 | $302 | $12 |
| Nitrofurantoin Mono-Macro | 14 | $291 | $21 |
| Metoprolol | 16 | $245 | $15 |
| Azithromycin | 23 | $176 | $8 |
| Lisinopril-Hydrochlorothiazide | 25 | $157 | $6 |
| Ramipril | 11 | $102 | $9 |
| Atenolol | 15 | $94 | $6 |
| Alprazolam | 18 | $84 | $5 |
| Citalopram Hbr | 12 | $48 | $4 |
2018: 23 drugs
| Advair Diskus | 14 | $9,118 | $651 |
| Levothyroxine | 95 | $1,991 | $21 |
| Atorvastatin | 73 | $1,284 | $18 |
| Rosuvastatin | 15 | $941 | $63 |
| Metformin | 71 | $598 | $8 |
| Losartan | 56 | $524 | $9 |
| Metoprolol | 15 | $425 | $28 |
| Simvastatin | 61 | $419 | $7 |
| Montelukast | 20 | $416 | $21 |
| Amlodipine Besylate | 66 | $391 | $6 |
| Allopurinol | 16 | $382 | $24 |
| Omeprazole | 22 | $362 | $16 |
| Lisinopril | 43 | $314 | $7 |
| Hydrochlorothiazide | 46 | $255 | $6 |
| Paroxetine | 16 | $249 | $16 |
| Metoprolol | 20 | $238 | $12 |
| Amoxicillin-Clavulanate Potass | 20 | $190 | $9 |
| Alendronate | 17 | $149 | $9 |
| Escitalopram | 11 | $146 | $13 |
| Azithromycin | 15 | $113 | $8 |
| Alprazolam | 23 | $109 | $5 |
| Hydralazine | 12 | $93 | $8 |
| Lisinopril-Hydrochlorothiazide | 19 | $74 | $4 |
2017: 17 drugs
| Levothyroxine | 78 | $1,431 | $18 |
| Losartan | 64 | $622 | $10 |
| Atorvastatin | 41 | $550 | $13 |
| Rosuvastatin | 11 | $441 | $40 |
| Metoprolol | 23 | $432 | $19 |
| Metformin | 56 | $429 | $8 |
| Simvastatin | 53 | $418 | $8 |
| Amlodipine Besylate | 60 | $353 | $6 |
| Montelukast | 13 | $212 | $16 |
| Lisinopril | 34 | $199 | $6 |
| Amoxicillin-Clavulanate Potass | 18 | $188 | $10 |
| Azithromycin | 19 | $144 | $8 |
| Valsartan-Hydrochlorothiazide | 13 | $120 | $9 |
| Hydrochlorothiazide | 18 | $98 | $5 |
| Alprazolam | 16 | $76 | $5 |
| Citalopram Hbr | 15 | $54 | $4 |
| Metformin Hcl Er | 11 | $27 | $2 |
2016: 29 drugs
| Advair Diskus | 11 | $4,604 | $419 |
| Rivastigmine | 13 | $2,334 | $180 |
| Levothyroxine | 79 | $1,527 | $19 |
| Proair Hfa | 14 | $750 | $54 |
| Metformin | 85 | $625 | $7 |
| Losartan | 68 | $529 | $8 |
| Amlodipine Besylate | 65 | $431 | $7 |
| Oxybutynin Chloride | 13 | $418 | $32 |
| Atorvastatin | 34 | $415 | $12 |
| Propranolol | 14 | $393 | $28 |
| Amoxicillin-Clavulanate Potass | 31 | $390 | $13 |
| Metoprolol | 12 | $313 | $26 |
| Montelukast | 19 | $308 | $16 |
| Simvastatin | 46 | $296 | $6 |
| Lisinopril | 37 | $255 | $7 |
| Triamterene-Hydrochlorothiazid | 16 | $221 | $14 |
| Metoprolol | 25 | $197 | $8 |
| Azithromycin | 29 | $193 | $7 |
| Citalopram Hbr | 32 | $174 | $5 |
| Hydrochlorothiazide | 30 | $153 | $5 |
| Trazodone | 13 | $151 | $12 |
| Alendronate | 19 | $146 | $8 |
| Alprazolam | 23 | $141 | $6 |
| Fluticasone Propionate | 11 | $117 | $11 |
| Glipizide | 14 | $108 | $8 |
| Sertraline | 22 | $108 | $5 |
| Cephalexin | 13 | $94 | $7 |
| Ciprofloxacin | 12 | $67 | $6 |
| Carvedilol | 11 | $63 | $6 |
2015: 23 drugs
| Crestor | 22 | $6,126 | $278 |
| Azor | 12 | $2,648 | $221 |
| Levothyroxine | 96 | $1,917 | $20 |
| Venlafaxine Hcl Er | 11 | $434 | $39 |
| Oxybutynin Chloride | 13 | $401 | $31 |
| Metformin | 54 | $376 | $7 |
| Metoprolol | 15 | $372 | $25 |
| Simvastatin | 49 | $372 | $8 |
| Amlodipine Besylate | 64 | $299 | $5 |
| Lisinopril | 37 | $291 | $8 |
| Losartan | 30 | $252 | $8 |
| Metoprolol | 23 | $198 | $9 |
| Amoxicillin-Clavulanate Potass | 14 | $196 | $14 |
| Hydrochlorothiazide | 32 | $174 | $5 |
| Citalopram Hbr | 38 | $155 | $4 |
| Azithromycin | 16 | $137 | $9 |
| Alendronate | 15 | $126 | $8 |
| Alprazolam | 14 | $103 | $7 |
| Sertraline | 12 | $81 | $7 |
| Atenolol | 11 | $81 | $7 |
| Glipizide | 14 | $79 | $6 |
| Allopurinol | 12 | $77 | $6 |
| Carvedilol | 13 | $64 | $5 |
2014: 31 drugs
| Levothyroxine | 116 | $2,218 | $19 |
| Pioglitazone | 11 | $969 | $88 |
| Proair Hfa | 15 | $737 | $49 |
| Simvastatin | 98 | $715 | $7 |
| Pravastatin | 17 | $691 | $41 |
| Amox Tr-Potassium Clavulanate | 33 | $613 | $19 |
| Metformin | 53 | $587 | $11 |
| Lisinopril | 87 | $577 | $7 |
| Alendronate | 26 | $475 | $18 |
| Nitrofurantoin Mono-Macro | 15 | $427 | $28 |
| Metoprolol | 14 | $415 | $30 |
| Omeprazole | 18 | $378 | $21 |
| Temazepam | 11 | $367 | $33 |
| Venlafaxine | 13 | $350 | $27 |
| Metoprolol | 33 | $337 | $10 |
| Fluticasone Propionate | 20 | $313 | $16 |
| Atorvastatin | 11 | $287 | $26 |
| Amlodipine Besylate | 41 | $265 | $6 |
| Triamterene-Hydrochlorothiazid | 15 | $261 | $17 |
| Losartan | 18 | $237 | $13 |
| Hydrochlorothiazide | 31 | $206 | $7 |
| Citalopram Hbr | 36 | $204 | $6 |
| Lovastatin | 13 | $198 | $15 |
| Montelukast | 13 | $186 | $14 |
| Azithromycin | 20 | $174 | $9 |
| Atenolol | 21 | $137 | $7 |
| Sertraline | 19 | $124 | $7 |
| Clopidogrel | 11 | $100 | $9 |
| Glipizide | 13 | $79 | $6 |
| Alprazolam | 14 | $77 | $5 |
| Escitalopram | 13 | $66 | $5 |
2013: 24 drugs
| Levothyroxine | 81 | $1,081 | $13 |
| Atorvastatin | 27 | $1,009 | $37 |
| Simvastatin | 74 | $612 | $8 |
| Lisinopril | 72 | $516 | $7 |
| Metformin | 42 | $412 | $10 |
| Pravastatin | 14 | $391 | $28 |
| Triamterene-Hctz | 22 | $380 | $17 |
| Metoprolol | 18 | $353 | $20 |
| Lovastatin | 15 | $349 | $23 |
| Losartan | 16 | $340 | $21 |
| Amox Tr-Potassium Clavulanate | 13 | $291 | $22 |
| Fluticasone Propionate | 11 | $229 | $21 |
| Hydrochlorothiazide | 35 | $219 | $6 |
| Omeprazole | 14 | $214 | $15 |
| Montelukast | 13 | $185 | $14 |
| Atenolol | 24 | $183 | $8 |
| Alendronate | 19 | $170 | $9 |
| Benazepril | 16 | $156 | $10 |
| Amlodipine Besylate | 19 | $154 | $8 |
| Citalopram Hbr | 26 | $143 | $5 |
| Sertraline | 12 | $89 | $7 |
| Cephalexin | 11 | $65 | $6 |
| Alprazolam | 16 | $53 | $3 |
| Metformin Hcl Er | 12 | $46 | $4 |
Professional record
- NPI
- 1548453830
- Licence
- CA A97286California A97286: Current · expires 2028-05-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 6475 Camden Ave Ste 105, San Jose, CA, 95120
- NPI first listed
- 2007-08-21
- NPI last updated
- 2024-04-25
- NPI record certified
- 2024-04-25
This is when the NPI record was last certified, not a medical board exam.